# Rigel Pharmaceuticals Inc: Form 8-K, filed Jun 27, 2024

- Company: [Rigel Pharmaceuticals Inc](/companies/rigl.md) (CIK 1034842)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 16:31 ET
- Period: 2024-06-27
- Accession: 0001104659-24-075697
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/tm2417992d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1034842/000110465924075697/tm2417992d2_8k.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-075697. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.